Abstract:Background: Colorectal carcinogenesis (CRC) is one of the most aggressive forms of cancer, particularly in developing countries. It accounts for the second and third-highest reason for cancer-induced lethality in women and men respectively. CRC involves genetic and epigenetic modifications in colonic epithelium, leading to colon adenocarcinoma. The current review highlights the pathogenic mechanisms and multifactorial etiology of CRC, influenced by apoptosis, inflammation, and autophagy pathways. Methods: We have carried out a selective literature review on mechanisms contributing to the pathogenesis of CRC. Results: Resistance to senescence and apoptosis of the mesenchymal cells, which play a key role in intestinal organogenesis, morphogenesis and homeostasis, appears important for sporadic CRC. Additionally, inflammation-associated tumorigenesis is a key incident in CRC, supported by immune disruptors, adaptive and innate immune traits, environmental factors, etc. involving oxidative stress, DNA damage and epigenetic modulations. The self-digesting mechanism, autophagy, also plays a twin role in CRC through the participation of LC3/LC3-II, Beclin-1, ATG5, other autophagy proteins, and Inflammatory Bowel Disease (IBD) susceptibility genes. It facilitates the promotion of effective surveillance pathways and stimulates the generation of malignant tumor cells. The autophagy and apoptotic pathways undergo synergistic or antagonistic interactions in CRC and bear a critical association with IBD that results from the pro-neoplastic effects of persistent intestinal inflammation. Conversely, pro-inflammatory factors stimulate tumor growth and angiogenesis and inhibit apoptosis, suppressing anti-tumor activities. Conclusion: Hence, research attempts for the development of potential therapies for CRC are in progress, primarily based on combinatorial approaches targeting apoptosis, inflammation, and autophagy.

Updates in the Research of Crohn's Disease Complicated by Colorectal Cancer

A Review of Compounds for Prevention of Colorectal Cancer

The updates on metastatic mechanism and treatment of colorectal cancer

Colitis-associated carcinogenesis: crosstalk between tumors, immune cells and gut microbiota

Advances in molecular mechanisms of inflammatory bowel disease‑associated colorectal cancer (Review)

Colorectal Cancer In Inflammatory Bowel Disease: Epidemiology, Pathogenesis And Surveillance

Advances in Epigenetic Biomarker Research in Colorectal Cancer.

Colorectal Cancer in Ulcerative Colitis: Mechanisms, Surveillance and Chemoprevention

Role of Inflammation in the Carcinogenesis of Colorectal Cancer

Molecular Network of Colorectal Cancer and Current Therapeutic Options

Colorectal Cancers: An Update on Their Molecular Pathology

Perspectives on the Treatment of Colorectal Carcinoma.

Colitis-associated neoplasia: molecular basis and clinical translation

Advances in research on the effectiveness and mechanism of Traditional Chinese Medicine formulas for colitis-associated colorectal cancer

[Risk factors and chemoprophylaxis of ulcerative colitis-colorectal cancer].

Molecular and cellular pathways in colorectal cancer: apoptosis, autophagy and inflammation as key players

Molecular Complexity of Colorectal Cancer: Pathways, Biomarkers, and Therapeutic Strategies

Research Progress on the Relationship Between Inflammation and Colorectal Cancer

Potential Diagnostic and Prognostic Implications

Exploring the Inflammatory Pathogenesis of Colorectal Cancer

Overview of research progress and application of experimental models of colorectal cancer